Urogen Pharma Competitors and Similar CompaniesClear all
Urogen Pharma's competitors and similar companies include ESSA Pharma and Fennec Pharma.
 ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. |  Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | ||
Founding Date | Founding Date 2004 | Founding Date 2009 | Founding Date 1996 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations US HQ |
Employees | Employees 194362% increase | Employees 35 | Employees 433% increase |
Valuation ($) | Valuation ($) 515.9 m | Valuation ($) 240 m | Valuation ($) 129.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $44.6m (FY, 2025) |
Net income | Net income ($153.5m) (FY, 2025) | Net income ($28.5m) (FY, 2024) | Net income ($9.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 74.1m | Total funding raised $ 2.2m |
For sources of this data, please see the company profile
View Company Profiles
ESSA Pharma
HQ
Vancouver, CA
Employees
35
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
View companyFennec Pharma
HQ
US
Employees
4↑ 33% increase
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View company